Family Office · Vilniaus M., Lithuania
Arkstone is a health technology company specializing in clinical decision support and laboratory reporting solutions, particularly in the field of infectious disease diagnostics. Founded in 2020 and headquartered in the United States, Arkstone leverages artificial intelligence to provide actionable insights from laboratory results, aiming to improve patient outcomes and antimicrobial stewardship. The company is recognized for its OneChoice report, which translates complex laboratory data into clear, evidence-based recommendations for healthcare providers. Arkstone has established partnerships with diagnostic laboratories and has gained attention for its innovative approach to combating antibiotic resistance and supporting precision medicine initiatives.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Arkstone deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. VC Boom tracks Arkstone alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
AEQUITA
Automotive, Industrial, Aerospace & Defense
Seed VC
Aera VC
Climate Tech, Climate tech, - Food tech
Seed VC
Aescuvest
DeepTech, Healthtech
Family Office
Aeternum Management AS
life sciences, healthcare, medical devices
Seed VC
AF Partners AG
Family Office
Afalon Investment Management
Private Equity, Private Debt, Alternatives
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Arkstone is one of them, and we'll tell you exactly where they sit in your top 100.